Literature DB >> 20602327

Retreatment of residual refractive errors with flap lift laser in situ keratomileusis.

Colm McAlinden1, Jonathan E Moore.   

Abstract

PURPOSE: To investigate the outcomes of flap lift laser-assisted in situ keratomileusis (LASIK) for residual refractive errors.
METHODS: In this prospective study, 60 eyes of 48 patients (mean age 36 years; age range 23-53 years) underwent flap lift retreatment surgery following initial LASIK for the correction of residual refractive errors. All treatments were wavefront guided using the VISX S4 Star excimer laser. The main outcome measures were predictability, safety, efficacy, and stability.
RESULTS: Following retreatment, epithelial ingrowth occurred in 23.3% (n=14) of eyes, which required a flap lift and scrape procedure in 4 eyes and a second flap lift and scrape procedure in 2 eyes. De novo dry eye occurred in 8.3% (n=5) of eyes. At 6 months, the mean (±SD) post-retreatment Snellen decimal uncorrected visual acuity (UCVA), sphere, cylinder, spherical equivalent (SE), defocus equivalent (DE), and best corrected visual acuity (BCVA) was 1.03±0.23, 0.08±0.34 diopters (D) (range -0.75 to +1.25 D), -0.53±0.37 D (range 0 to -1.75 D), -0.04±0.34 D (range -1.11 to +1.04 D), 0.29±0.41 D (range 0 to 1.94 D), and 1.13±0.15 (range 0.5 to 1.5), respectively. Seventy-three percent (n=44) of eyes had an UCVA equal to or greater than 1 (6/6), 88.3% (n=53) and 98.3% (n=59) of eyes were within ±0.50 D and ±1.00 D of SE, respectively, and 3.3% (n=2) of eyes lost 1 line of BCVA.
CONCLUSIONS: A high incidence (23.3%, n=14) of epithelial ingrowth occurred following retreatment surgery and de novo dry eye occurred in 8.3% (n=5) of eyes. Despite this, reasonable visual and refractive outcomes were achieved at 6 months post-retreatment.

Entities:  

Mesh:

Year:  2011        PMID: 20602327     DOI: 10.5301/ejo.2010.391

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  6 in total

1.  3-Year follow-up after Lasik: assessing the risk factors for retreatment.

Authors:  Jorge E Valdez-García; Julio C Hernandez-Camarena; Rosa Martínez-Muñoz
Journal:  Int Ophthalmol       Date:  2015-05-19       Impact factor: 2.031

Review 2.  Epithelial ingrowth following laser in situ keratomileusis (LASIK): prevalence, risk factors, management and visual outcomes.

Authors:  Darren Shu Jeng Ting; Sathish Srinivasan; Jean-Pierre Danjoux
Journal:  BMJ Open Ophthalmol       Date:  2018-03-29

3.  Femtosecond-Assisted Laser in situ Keratomileusis with de novo Flap Creation Following Previous Microkeratome Laser in situ Keratomileusis.

Authors:  Sloan W Rush; Ryan B Rush
Journal:  Clin Ophthalmol       Date:  2021-04-30

4.  Laser-Assisted In Situ Keratomileusis (LASIK) Enhancement for Residual Refractive Error after Primary LASIK.

Authors:  Majid Moshirfar; Noor F Basharat; Nour Bundogji; Emilie L Ungricht; Ines M Darquea; Matthew E Conley; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  J Clin Med       Date:  2022-08-18       Impact factor: 4.964

Review 5.  Femtosecond laser cataract surgery.

Authors:  Zoltan Z Nagy; Colm McAlinden
Journal:  Eye Vis (Lond)       Date:  2015-06-30

6.  Safety and efficacy of VisuMax® circle patterns for flap creation and enhancement following small incision lenticule extraction.

Authors:  Ekktet Chansue; Morakot Tanehsakdi; Sukanda Swasdibutra; Colm McAlinden
Journal:  Eye Vis (Lond)       Date:  2015-12-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.